Dragomabin is a lipopeptide isolated from the marine cyanobacteria Lyngbya majuscula. It has in vitro antimalarial activity. In 2018, a laboratory synthesis of dragomabin was reported.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.